Patent | Date |
---|
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment Grant 8,552,022 - Wood , et al. October 8, 2 | 2013-10-08 |
Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment Grant 8,445,499 - Wood , et al. May 21, 2 | 2013-05-21 |
Acyl bipiperidinyl compounds useful as GPR 119 agonists Grant 8,399,485 - Wood , et al. March 19, 2 | 2013-03-19 |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment Grant 8,343,990 - Wood , et al. January 1, 2 | 2013-01-01 |
Bipiperidinyl Compounds, Compositions, Containing Such Compounds And Methods Of Treatment App 20120178681 - WOOD; HAROLD B. ;   et al. | 2012-07-12 |
Substituted Cyclopropyl Compounds, Compositions Containing Such Compounds And Methods Of Treatment App 20120142706 - Wood; Harold B. ;   et al. | 2012-06-07 |
Substituted Cyclopropyl Compounds, Compositions Containing Such Compounds And Methods Of Treatment App 20110028501 - Wood; Harold B ;   et al. | 2011-02-03 |
Acyl Bipiperidinyl Compounds, Compositions Containing Such Compounds And Methods Of Treatment App 20100075987 - Wood; Harold B. ;   et al. | 2010-03-25 |
Bipiperidinyl Compounds, Compositions Containing Such Compounds And Methods Of Treatment App 20100029688 - Wood; Harold B. ;   et al. | 2010-02-04 |
Thiazole Derivatives as CXCR3 Receptor Modulators App 20090143413 - Adams; Alan D. ;   et al. | 2009-06-04 |
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders Grant 7,495,020 - Adams , et al. February 24, 2 | 2009-02-24 |
Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators App 20090030012 - Adams; Alan D. ;   et al. | 2009-01-29 |
Therapeutic compounds for treating dyslipidemic conditions Grant 7,125,865 - Jones , et al. October 24, 2 | 2006-10-24 |
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders Grant 7,091,230 - Adams , et al. August 15, 2 | 2006-08-15 |
Therapeutic compounds for treating dyslipidemic conditions App 20060178398 - Adams; Alan D. ;   et al. | 2006-08-10 |
2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders App 20060122242 - Adams; Alan D. ;   et al. | 2006-06-08 |
Therapeutic compounds for treating dyslipidemic conditions App 20050239769 - Jones, A. Brian ;   et al. | 2005-10-27 |
Therapeutic compounds for treating dyslipidemic conditions Grant 6,908,934 - Adams , et al. June 21, 2 | 2005-06-21 |
Therapeutic compounds for treating dyslipidemic conditions App 20050113419 - Huang, Shaei Y. ;   et al. | 2005-05-26 |
Therapeutic compounds for treating dyslipidemic conditions App 20050014807 - Adams, Alan D ;   et al. | 2005-01-20 |
Therapeutic compounds for treating dyslipidemic conditions App 20040266849 - Adams, Alan D ;   et al. | 2004-12-30 |
2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders App 20040092596 - Adams, Alan D. ;   et al. | 2004-05-13 |
Therapeutic compounds for treating dyslipidemic conditions App 20030125357 - Adams, Alan D. ;   et al. | 2003-07-03 |
Antidiabetic agents Grant 6,090,839 - Adams , et al. July 18, 2 | 2000-07-18 |
Antidiabetic agents Grant 5,859,051 - Adams , et al. January 12, 1 | 1999-01-12 |
Inhibitors of peptide binding to MHO class II proteins Grant 5,817,757 - Adams , et al. October 6, 1 | 1998-10-06 |
Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins Grant 5,719,296 - Acton, III , et al. February 17, 1 | 1998-02-17 |